论文部分内容阅读
近年来人们通过对胃癌淋巴转移规律的研究并在治疗方法上改进,虽取得了一些进展,但总体疗效仍不尽人意。临床资料表明胃癌腹膜转移和术后复发已成为影响疗效的关键因素之一,出现腹膜转移或复发,五年生存率低于20％。由于腹膜转移早期无特异临床症状,晚期又常合并其它脏器的转移,同时术前缺乏有效的诊断手段,因而无确切发生率的统计数字;但根据术中所见进展期胃癌腹膜转移的发生率约10％。在胃癌术后复发的诸类型中腹
In recent years, people through the study of lymph node metastasis of gastric cancer and improve the treatment methods, although some progress has been made, but the overall effect is still unsatisfactory. Clinical data show that peritoneal metastases and postoperative recurrence of gastric cancer has become one of the key factors affecting the efficacy of peritoneal metastasis or recurrence, five-year survival rate of less than 20%. Due to the early no specific clinical symptoms of peritoneal metastasis, advanced and often combined with the transfer of other organs, while the lack of effective preoperative diagnosis, and therefore no exact incidence of statistics; but according to the intraoperative findings of advanced gastric cancer peritoneal metastasis occurred Rate of about 10%. Recurrence of various types of stomach cancer after surgery in the abdomen